JP2012001565A5 - - Google Patents

Download PDF

Info

Publication number
JP2012001565A5
JP2012001565A5 JP2011219630A JP2011219630A JP2012001565A5 JP 2012001565 A5 JP2012001565 A5 JP 2012001565A5 JP 2011219630 A JP2011219630 A JP 2011219630A JP 2011219630 A JP2011219630 A JP 2011219630A JP 2012001565 A5 JP2012001565 A5 JP 2012001565A5
Authority
JP
Japan
Prior art keywords
patient
immunogenic composition
influenza virus
langerhans cells
immunogenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011219630A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012001565A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2012001565A publication Critical patent/JP2012001565A/ja
Publication of JP2012001565A5 publication Critical patent/JP2012001565A5/ja
Pending legal-status Critical Current

Links

JP2011219630A 2004-11-03 2011-10-03 インフルエンザワクチン接種 Pending JP2012001565A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62497304P 2004-11-03 2004-11-03
US60/624,973 2004-11-03

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2007540074A Division JP2008519042A (ja) 2004-11-03 2005-11-03 インフルエンザワクチン接種

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014081555A Division JP2014132035A (ja) 2004-11-03 2014-04-11 インフルエンザワクチン接種

Publications (2)

Publication Number Publication Date
JP2012001565A JP2012001565A (ja) 2012-01-05
JP2012001565A5 true JP2012001565A5 (enExample) 2013-04-11

Family

ID=36578359

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2007540074A Pending JP2008519042A (ja) 2004-11-03 2005-11-03 インフルエンザワクチン接種
JP2011219630A Pending JP2012001565A (ja) 2004-11-03 2011-10-03 インフルエンザワクチン接種
JP2014081555A Pending JP2014132035A (ja) 2004-11-03 2014-04-11 インフルエンザワクチン接種

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2007540074A Pending JP2008519042A (ja) 2004-11-03 2005-11-03 インフルエンザワクチン接種

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014081555A Pending JP2014132035A (ja) 2004-11-03 2014-04-11 インフルエンザワクチン接種

Country Status (9)

Country Link
US (2) US20090004222A1 (enExample)
EP (2) EP1807116B1 (enExample)
JP (3) JP2008519042A (enExample)
CN (1) CN101076355A (enExample)
AU (1) AU2005314563B2 (enExample)
CA (1) CA2586690A1 (enExample)
ES (1) ES2542020T3 (enExample)
HK (1) HK1214534A1 (enExample)
WO (1) WO2006062637A2 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2816222A1 (en) 2003-06-16 2005-03-03 Medimmune Vaccines, Inc. Influenza hemagglutinin and neuraminidase variants
ES2527503T3 (es) * 2005-03-08 2015-01-26 Medimmune, Llc Virus influenza reordenantes
BRPI0915487A2 (pt) * 2008-07-11 2017-06-27 Medimmune Inc hemaglutina de nfluenza e variantes de neuraminidase
CN102112151A (zh) 2008-07-30 2011-06-29 久光制药株式会社 微针装置及由微针装置使日本脑炎病毒抗原的功效升高的方法
IN2014CN02114A (enExample) * 2011-09-20 2015-05-29 Sinai School Medicine
TR201807340T4 (tr) * 2013-02-01 2018-06-21 Glaxosmithkline Biologicals Sa Çan benzeri reseptör agonistleri içeren immünolojik kompozisyonların intradermal yoldan verilmesi.
CA3080656A1 (en) 2017-10-30 2019-05-09 Baxalta GmbH Environmentally compatible detergents for inactivation of lipid-enveloped viruses
EP3740241A1 (en) * 2018-01-18 2020-11-25 eTheRNA Immunotherapies NV Lipid nanoparticles
CN115734798A (zh) 2020-04-28 2023-03-03 提克纳有限责任公司 微针组件

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1122527A (en) 1979-05-15 1982-04-27 Karen K. Brown Influenza vaccine production in liquid cell culture
HU212924B (en) * 1989-05-25 1996-12-30 Chiron Corp Adjuvant formulation comprising a submicron oil droplet emulsion
IL99851A (en) 1990-10-30 1996-06-18 Daiichi Seiyaku Co Muramyldipeptide derivatives and influenza vaccine containing them
WO1994019013A1 (en) 1993-02-19 1994-09-01 Smithkline Beecham Corporation Influenza vaccine compositions containing 3-o-deacylated monophosphoryl lipid a
ES2162139T5 (es) * 1993-03-23 2008-05-16 Smithkline Beecham Biologicals S.A. Composiciones de vacuna que contienen monofosforil-lipido a 3-o-desacilado.
GB9500788D0 (en) 1995-01-16 1995-03-08 Medeva Holdings Bv Vaccine compositions
EP0865296B1 (en) 1995-10-20 2002-02-27 Yissum Research Development Company Of The Hebrew University Of Jerusalem Influenza vaccine
DE19612966B4 (de) 1996-04-01 2009-12-10 Novartis Vaccines And Diagnostics Gmbh & Co. Kg MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren
TW570803B (en) 1997-04-09 2004-01-11 Duphar Int Res Influenza vaccine
GB9725084D0 (en) 1997-11-28 1998-01-28 Medeva Europ Ltd Vaccine compositions
US6503231B1 (en) 1998-06-10 2003-01-07 Georgia Tech Research Corporation Microneedle device for transport of molecules across tissue
AT408615B (de) 1998-09-15 2002-01-25 Immuno Ag Neue influenzavirus-impfstoffzusammensetzung
US6611707B1 (en) 1999-06-04 2003-08-26 Georgia Tech Research Corporation Microneedle drug delivery device
GB9923176D0 (en) 1999-09-30 1999-12-01 Smithkline Beecham Biolog Novel composition
US6843781B2 (en) * 1999-10-14 2005-01-18 Becton, Dickinson And Company Intradermal needle
GB0017999D0 (en) 2000-07-21 2000-09-13 Smithkline Beecham Biolog Novel device
US20040096463A1 (en) * 2001-02-23 2004-05-20 Nathalie Garcon Novel vaccine
CA2438942A1 (en) * 2001-02-23 2002-09-26 Glaxosmithkline Biologicals S.A. Influenza vaccine formulations for intradermal delivery
US20020193729A1 (en) * 2001-04-20 2002-12-19 Cormier Michel J.N. Microprojection array immunization patch and method
TWI228420B (en) * 2001-05-30 2005-03-01 Smithkline Beecham Pharma Gmbh Novel vaccine composition
CA2451816A1 (en) * 2001-06-29 2003-01-09 Becton, Dickinson And Company Intradermal delivery of vaccines and gene therapeutic agents via microcannula
FR2836924B1 (fr) * 2002-03-08 2005-01-14 Vivalis Lignees de cellules aviaires utiles pour la production de substances d'interet
US7588774B2 (en) * 2003-05-12 2009-09-15 Becton, Dickinson And Company Molecules enhancing dermal delivery of influenza vaccines
US20050123550A1 (en) 2003-05-12 2005-06-09 Laurent Philippe E. Molecules enhancing dermal delivery of influenza vaccines
BRPI0509493A (pt) * 2004-04-01 2007-09-11 Alza Corp aparelho e método para a liberação transdérmica de vacina da influenza
JP5666905B2 (ja) * 2007-06-18 2015-02-12 メディミューン，エルエルシー ヘマグルチニンポリペプチド中に変化を有するインフルエンザｂウイルス

Similar Documents

Publication Publication Date Title
JP2012001565A5 (enExample)
JP2009173664A5 (enExample)
JP2012072157A5 (enExample)
WO2014103488A1 (ja) 経鼻インフルエンザワクチン組成物
WO2006060710A3 (en) Vaccine formulations for intradermal delivery comprising adjuvants and antigenic agents
TW200722101A (en) Novel composition
AR083361A1 (es) Forma de dosificacion de rapida disolucion de vacuna oral utilizando almidon
JP2013505205A5 (enExample)
NZ585674A (en) Vaccination with multiple clades of h5 influenza a virus
WO2007095976A3 (de) Adjuvanz in form einer lipid-modifizierten nukleinsäure
CR10559A (es) Vacuna de influenza
WO2013098655A9 (en) Vaccines directed against human enteroviruses
HRP20141258T1 (hr) 6-amino-2-{[(1s)-1-metilbutil]oksi}-9-[5-(1-piperidinil)pentil]-7,9-dihidro-8h-purin-8-on maleat
JP2013536240A5 (enExample)
JP2009539965A5 (enExample)
NZ597000A (en) Compositions and methods for administration of vaccines against dengue virus
NZ606993A (en) Combination pharmaceutical composition and methods of treating and preventing the infectious diseases
JP2015520196A5 (enExample)
MX2011008923A (es) Composicion inmunogena.
HRP20141063T1 (hr) Cjepivo protiv hpv
JP2015531389A5 (enExample)
JP2016531895A5 (enExample)
JP2014515035A5 (enExample)
JP2011529475A5 (enExample)
JP2016521754A5 (enExample)